Tag Archives: Eye diseases

August, 2018

• 30 August

  ProLynx and Daiichi Sankyo Announce the Development of Technology for Half-Life Extension of Small Molecules in the Eye

  

  SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) — ProLynx and Daiichi Sankyo Company, Limited, announced today the publication of a paper in the journal TVST entitled “A controlled release system for long-acting intravitreal delivery of small molecules”. In this work, they described a technology to extend the intravitreal half-life of …

  Share

  • Facebook
  • Twitter
  • LinkedIn

March, 2016

• 25 March

  Bayer and Regeneron Partner to Develop Novel Combination Therapy for Eye Diseases

  

  TARRYTOWN, N.Y., March 24, 2016 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer will jointly develop a combination therapy of the angiopoietin2 (Ang2) antibody nesvacumab and the vascular endothelial growth factor (VEGF) trap aflibercept, for the treatment of serious eye diseases. Two separate Phase 2 clinical studies are evaluating …

  Share

  • Facebook
  • Twitter
  • LinkedIn